On behalf of IFARA, CARE community advisory board coordinator Jeff Taylor spoke with Paula Cannon, Ph.D., Karine Dubé and Warner Greene, M.D., Ph.D., about research into a cure for HIV. One potential avenue is gene therapy that would modify a person's own immune system either to make that person's cells immune to HIV or to prompt them to attack the virus. Similar strategies are being developed for cancer treatment, and researchers involved in either disease are "knocking on each other's doors," Greene said. Another path is a "shock and kill" strategy whereby toll-like receptor antagonists are used to trigger a person's innate immune system, then a novel vaccine is injected to kill the reactivated cells. However, it is difficult to find people willing to participate in such studies. CARE developed a curriculum to make cure research accessible to HIV-affected communities in order to improve enrollment in such trials. The organization will also be soliciting community feedback at this year's AIDS conference in Durban, South Africa, among other venues.
Watch the video to learn more:
About the panelists:
Paula Cannon, Ph.D., University of Southern California, Los Angeles, Calif.
Karine Dubé, DrPH candidate and program manager, Collaboratory of AIDS Researchers for Eradication (CARE) at the University of North Carolina, Chapel Hill, N.C.
Warner C. Greene, M.D., Ph.D., Gladstone Institutes at the University of California, San Francisco, San Francisco, Calif.
The video above has been posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website or YouTube channel to watch more video interviews from the CROI 2016 conference, as well as earlier meetings.